2m 2m 2m 2m 2m 2m 2m
EQUILLIUM (EQ)
NASDAQ
$2.14+$0.02 (+1.18%)
Price as of Sep 11, 2026 7:46 PM EDT- $133.8MMarket Cap
- 12.83%1-Year Change
- BiotechnologyIndustry
EQUILLIUM (EQ)
$2.14+$0.02 (+1.18%)
EQ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.11 | ||
Change | -$0.31 (-12.81%) | ||
Open | $2.46 | ||
High | $2.46 | ||
Low | $2.11 | ||
Previous Close | $2.42 | ||
Volume | 554,046 | ||
30-Day Average Volume | 431,868 | ||
1-Week Change | -4.52% | ||
1-Month Change | -5.38% | ||
1-Year Change | 12.83% | ||
3-Year Change | 163.75% | ||
5-Year Change | -63.87% | ||
Fundamentals | |||
Shares Outstanding | 63.4M | ||
Total Assets | $58.7M | ||
Market Cap | $133.8M | ||
Enterprise Value | $76.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.7M | ||
Net Working Capital | $55.5M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -53 | ||
PEG | -2 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 06/12/2009 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue